|
|
 |
|
¡¡ |
|
¡¡ |
|
|
|
¡¡ |
HOME > ÇÐȸ°£Ç๰ >
¿ë¾î»çÀü |
|
Á¦¸ñ |
The Studies on Antifungal Activities of Synthetic Thiocarbanilides (L-1 and L-4) in vitro |
|
|
|
|
ÀúÀÚ |
Kook Bo Kim, and Joon Lew |
¼Ò¼Ó |
Department of Microbiology, College of Medicine, Yonsei University |
|
|
³âµµ |
1967 |
±Ç |
4 |
|
|
È£ |
1 |
¹øÈ£ |
|
|
|
½ÃÀÛÆäÀÌÁö |
13 |
³¡ÆäÀÌÁö |
39 |
|
|
÷ºÎ |
|
|
|
¿ä¾à |
In nature there are many kinds of fungi, which have close relations with animals and plants in various ways. Among these fungi, some cause diseases in man. For a long time the biological and biochemical characteristics of fungi and diseases caused by them have been studied by many workers. At present, superficial fungal infection is widely prevalent, covering all of races and areas, and has been recognized as a serious problem among all nations. Especially soldiers serving in moist and hot areas mostly suffer from athlete's foot. Despite these circumstances, to our regret, there are no ideal chemotherapeutic agents, but some used now are effective. Emmons studied antifungal activities against superficial mycoses with several disinfectants, and Loewenthal made a similar study with alcohol. Griseofulvin, which Oxford et al. isolated from Penicillium griseofulvum, is widely used as a chemotherapeutic agent for superficial mycoses, and its activities were studied by many workers. Other compounds tested for their antifungal activities were Candicidin isolated from Streptomyces griseus by Lechevalier et al., Fungicidin from Actinomyces by Hazen et al., Mycobacillin from Bacillus subtilis by Majumdar and Bose, Hamycin from Streptomyces pimprina by Bennett, and Amphotericin A and B from the other strains of Streptomyces by Fraser and Knox. Noguchi et al. of Japan synthesized Tolnaftate and claimed that it has excellent antifungal activity against superficial fungal infections. Robinson and Rasm, and Robinson and Raskin carried out clinical trials with Tolnaftate and reported the results indicated that Tolnaftate was highly effective against superficial fungal infections. Robinson et al., Fleischmajer, Blank and Stone et al. studied antifungal activities with Thiabendazole, Melges with Candeptin, Olansky with Nafcillin, Hazen et al. and Wright et al. with Nystatin, Fraser and Knok, Kravetz et al., Rosenthal and Spinner et al. with Amphotericin 3, and Uts with various chemical compounds. These investigators presented data showing that some of those chemicals possessed antifungal activities against deep mycotic infections. Antifungal activities of ten different chemicals were compared by Mayer, and similar studies were made with Imidazole derivatives by Ellis, with several antileprosy and antituberculosis chemotherapeutic agents by Woo et al., and with Undecylenic acid and Tolnaftate by Lubowe et al. For a long time it has been known that fungi have similar characteristics and close relations to mycobacteria from the point of view of phylogenetic taxonomy. It has been speculated that compounds which have suppressive effects on mycoses would be similarly suppressive to Mycobacterium tuberculosis and other mycobacteria such as Mycobacterium lepraemurlum and Mycobacterium leprae. Mayer, Lorincz and Pearson (1962), Woo et al., and Albright and Hitch reported that antimycobacterial agents were effective in treating fungal infections. Choi and Lew reported that a series of newly synthetic thiocarbanilides, L-1 and L-4, had remarkably suppressive activities against Mycobacterium lepraemurium and Mycobacterium tuberculosis. It was also shown that the same thiocarbanilides in vitro tests everted remarkable growth-inhibiting activities against the drug-resistant strains of Mycobacterium tuberculosis, but not so effective suppressive activities against non-mycobacterial pyogenic bacteria. They suggested that the antibacterial activities against mycobacteria and fungi of synthetic thiocarbanilides L-1 and L-4 were specific and selective ones. In the hope of finding a superior chemotherapeutic agent against fungal infections, in this investigation L-1 and L-4, synthetic thiocarbanilides which were originally developed as chemotherapeutic compounds for Mycobacterium tuberculosis and Mycobacterium leprae, were tested in vitro for their antifungal activities against superficial and deep mycoses. |
|
|
³»¿ë |
|
 | |
¡¡ |
|
|
|
|
|
|
|
|